Clinical Neuropathology QUIZ #19
Published in Clinical Neuropathology Vol 42 nr.3 (May-June 2023). Based on papers and editorial of Clinical Neuropathology of the same issue: https://www.dustri.com/nc/journals-in-english/mag/clinical-neuropathology/vol/volume-42-2023/issue/mayjune-16.html
Sign in to Google to save your progress. Learn more

1. Which of the following is a limiting factor in neuropathological research of autoimmune encephalitides?

*
1 point

2. Which of the following is a histological feature of Rasmussen encephalitis?

*
1 point

3. Which of the following tumors may harbor a KIAA1549::BRAF fusion?

*
1 point
4. Which of the following testing modalities for the detection of H3-3A mutations seems to have low sensitivity based on the results of the QuIP round robin trial? *
1 point

5 - Clasmatodendrosis may be observed in which of the following conditions?

*
1 point

6. Which of the following immunohistochemical markers highlights clasmatodendrosis best?

*
1 point

7. Which of the following histological descriptions best fits a diagnosis of inflammatory myofibroblastic tumor?

*
1 point

8. Which of the following immunohistochemical markers is specific for inflammatory myofibroblastic tumor involving the CNS?

*
1 point

9. Which of the following lymphomas involving the CNS is most likely to have an unusual clinical presentation and/or radiographic features?

*
1 point

10. Which of the following clinical indication for biopsy of a non-neoplastic lesion of the CNS is most frequent?

*
1 point
Submit
Clear form
This form was created inside of Euro-CNS. Report Abuse